Comments
Loading...
Actinium Pharma (AMEX:ATNM) Stock, Earnings Estimates, EPS, And Revenue
Actinium Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 28
EPS Estimate
$-0.390
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$81.00 K
Analyze the earnings history of Actinium Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Actinium Pharma (ATNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-0.37 | $-0.36 | -2.78 % |
| Jun 2024 | 2024-08-05 | $-0.38 | $-0.40 | 5.00 % |
| Mar 2024 | 2024-04-26 | $-0.31 | $-0.52 | 40.4 % |
| Dec 2023 | 2024-03-29 | $-0.33 | $-0.54 | 38.9 % |
Actinium Pharma (ATNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2023 | 2023-11-02 | $0 | $570.00K | -100.0 % |
| Mar 2023 | 2023-04-03 | $0 | $1.03M | -100.0 % |
FAQ
When is Actinium Pharma (AMEX:ATNM) reporting earnings?
Actinium Pharma (ATNM) is scheduled to report earnings on March 28, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Actinium Pharma (AMEX:ATNM)?
The Actual EPS was $-0.37, which missed the estimate of $-0.36.
What were Actinium Pharma’s (AMEX:ATNM) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.